Details
Title
Molecular docking, synthesis and biological evaluation of Vascular Endothelial Growth Factor (VEGF) B based peptide as antiangiogenic agent targeting the second domain of the Vascular Endothelial Growth Factor Receptor 1 (VEGFR1D2) for anticancer application
Author
Sadremomtaz Afsaneh 1 ; Ali, Ameena M 2 ; Foroozan, Jouyandeh 3 ; Balalaie Saeed 4 ; Navari Razieh 4 ; Broussy Sylvain 5
; Mansouri Kamran 6 ; Groves, Matthew R 1 ; Mohsen, Asghari S 7
1 University of Groningen, XB20 Drug Design, Groningen Research Institute of Pharmacy, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981)
2 University of Groningen, XB20 Drug Design, Groningen Research Institute of Pharmacy, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); Hamad Bin Khalifa University (HBKU), Qatar Biomedical Research Institute (QBRI), Doha, Qatar (GRID:grid.452146.0) (ISNI:0000 0004 1789 3191)
3 University of Guilan, Department of Biology, Faculty of Sciences, Rasht, Iran (GRID:grid.411872.9) (ISNI:0000 0001 2087 2250)
4 K. N. Toosi University of Technology, Peptide Chemistry Research Center, K.N. Toosi University of Technology, Tehran, Iran (GRID:grid.411976.c) (ISNI:0000 0004 0369 2065)
5 University of Paris, Faculty of Pharmacy of Paris, CiTCoM, 8038 CNRS, U 1268 INSERM, Paris, France (GRID:grid.10988.38) (ISNI:0000 0001 2173 743X)
6 Kermanshah University of Medical Sciences, Medical Biology Research Center, Kermanshah, Iran (GRID:grid.412112.5) (ISNI:0000 0001 2012 5829)
7 University of Guilan, Department of Biology, Faculty of Sciences, Rasht, Iran (GRID:grid.411872.9) (ISNI:0000 0001 2087 2250); University of Tehran, Institute of Biochemistry and Biophysics (IBB), Tehran, Iran (GRID:grid.46072.37) (ISNI:0000 0004 0612 7950)
; Mansouri Kamran 6 ; Groves, Matthew R 1 ; Mohsen, Asghari S 7 1 University of Groningen, XB20 Drug Design, Groningen Research Institute of Pharmacy, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981)
2 University of Groningen, XB20 Drug Design, Groningen Research Institute of Pharmacy, Groningen, The Netherlands (GRID:grid.4830.f) (ISNI:0000 0004 0407 1981); Hamad Bin Khalifa University (HBKU), Qatar Biomedical Research Institute (QBRI), Doha, Qatar (GRID:grid.452146.0) (ISNI:0000 0004 1789 3191)
3 University of Guilan, Department of Biology, Faculty of Sciences, Rasht, Iran (GRID:grid.411872.9) (ISNI:0000 0001 2087 2250)
4 K. N. Toosi University of Technology, Peptide Chemistry Research Center, K.N. Toosi University of Technology, Tehran, Iran (GRID:grid.411976.c) (ISNI:0000 0004 0369 2065)
5 University of Paris, Faculty of Pharmacy of Paris, CiTCoM, 8038 CNRS, U 1268 INSERM, Paris, France (GRID:grid.10988.38) (ISNI:0000 0001 2173 743X)
6 Kermanshah University of Medical Sciences, Medical Biology Research Center, Kermanshah, Iran (GRID:grid.412112.5) (ISNI:0000 0001 2012 5829)
7 University of Guilan, Department of Biology, Faculty of Sciences, Rasht, Iran (GRID:grid.411872.9) (ISNI:0000 0001 2087 2250); University of Tehran, Institute of Biochemistry and Biophysics (IBB), Tehran, Iran (GRID:grid.46072.37) (ISNI:0000 0004 0612 7950)
Publication year
2020
Publication date
2020
ISSN
20959907
e-ISSN
20593635
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2409608700
Copyright
© The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.